Verition Fund Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-700
Closed -$379K 3270
2024
Q2
$379K Buy
+700
New +$370K ﹤0.01% 2211
2023
Q1
Sell
-2,500
Closed -$1.28M 2250
2022
Q4
$1.28M Hold
2,500
0.02% 809
2022
Q3
$1.14M Buy
+2,500
New +$1.2M 0.01% 1294
2022
Q2
Sell
-2,900
Closed -$1.42M 2546
2022
Q1
$1.42M Buy
2,900
+2,200
+314% +$1.01M 0.02% 1222
2021
Q4
$324K Buy
+700
New +$294K ﹤0.01% 1942

Other funds holding ELV

Verition Fund Management's ELV Position: Q2 2026 in Review

Verition Fund Management increased its Elevance Health (ELV) stake by 28% in Q2 2026, buying an estimated $1.31M and bringing the position to 16,138 shares worth $6.24M. The position accounts for 0.03% of the portfolio, ranked #562.

Verition Fund Management first reported a position in ELV in Q3 2013 and has held it in 47 quarters since. The position peaked at $73.7M in Q4 2023. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Verition Fund Management held 16,138 shares of Elevance Health worth $6.24M as of Q2 2026.
  • Verition Fund Management bought 3,531 Elevance Health shares in Q2 2026, an estimated $1.31M.
  • Elevance Health made up 0.03% of Verition Fund Management's portfolio in Q2 2026, its #562 holding.
  • Verition Fund Management first reported a position in Elevance Health in Q3 2013 and has held it in 47 quarters since.
  • Verition Fund Management's Elevance Health position peaked at $73.7M in Q4 2023.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.